Policybazaar

Insurance companies expect the episode to not only prompt immediate spike in queries but also trigger longer-term behavioural shift

Pollution pushes health insurance claims up 14% post-Diwali across various cities as respiratory, cardiac cases surge

This comes amid long-standing discussions within the industry about introducing city-specific health insurance premiums that factor in air pollution levels as a key risk indicator.

PB Fintech may miss guidance of Rs 1,000 crore profit by FY27 following GST cut on health, life insurance

The removal of GST on insurance premiums is expected to significantly erode PB Fintech’s commission revenues, which will put its Rs 1,000 crore FY27 profit target at risk.

What led to the selloff in PB Fintech shares: IRDAI's regulatory action explained

IRDAI's action dates back to June 2020 when it conducted a remote inspection of PolicyBazaar’s operations during its IWA tenure and found irregularities in how it managed the sales processes, disclosures, partnerships, and premium flows.

PB Fintech shares fall after disclosure shows fine by IRDAI over regulatory lapses

IRDAI had inspected Policybazaar back in June 2020 and had issued a show-cause notice to PB Fintech in October 2024.

PB Fintech net profit soars 4x to Rs 85 crore, revenue grows by 36% to Rs 1,348 crore

PB Fintech has seen its UAE insurance premium grow by 68 percent YoY with the business aligning more towards health and life insurance, similar to the company’s India business

PB Fintech block deal: Stake worth Rs 920 crore sold, co-founder likely sellers

According to reports, PB Fintech co-founders are likely to offload 50.5 lakh shares, equaling to 1.1 percent of the total equity in the firm.

Didn’t know Zomato, PolicyBazaar would become so big: InfoEdge Ventures partners on finding generational companies

In a freewheeling chat with Moneycontrol, partners Chinmaya Sharma and Kitty Agarwal break down why small funds outperform, how they spot billion-dollar bets early, and why quick commerce and “Bharat” are top of mind.

PB Fintech shares rise 3% on a near three-fold rise in net profit: Should you buy, sell or hold?

Morgan Stanley kept an 'Underweight' call PB Fintech shares, with a target price of Rs 1,130 apiece. This implies a downside potential of over 36 percent from the stock's previous closing price.

Info Edge sitting on nearly 10X gains by betting Rs 3,959 crore on Zomato, PolicyBazaar, Naukri, others

The company has invested Rs 3,959 crore across platforms like Zomato, Policybazaar, and Naukri — a portfolio now valued at Rs 36,855 crore - delivering a gross internal rate of return (IRR) of 36 percent, according to the firm’s FY25 annual letter to shareholders.

Nearly half of Indians still skip term insurance: Policybazaar report

Jargon-filled terms and conditions and lack of clear communication from insurers have made insurance a product that people either delay or avoid altogether, the report added.

Term insurance purchases by self-employed surge 58% in FY25

Policybazaar data reveals over Rs 1-crore cover gaining traction among Gen z and Millennial entrepreneurs

PNB MetLife launches pension premier multi-cap fund in partnership with Policybazaar

The fund will be open for subscription till April 15 at an initial Net Asset Value of Rs 10

Consider regulators another CXO in fintech: PB Fintech’s Alok Bansal

Bansal noted that regulatory interventions can often be “very drastic” and sometimes even “unpredictable.”

PB Fintech shares soar 7% after Kotak's ratings upgrade, upbeat growth outlook

Amid expectations of strong future growth and cheaper valuations after the recent correction, Kotak assigned a price target of Rs 1,525 for PB Fintech, anticipating a near 13 percent upside.

Leadership changes at PB Fintech: Paisabazaar CEO Naveen Kukreja steps down, Santosh Agarwal to succeed him

Kukreja will continue to be aligned with PB Fintech, and a valued senior leader, the company said. He will continue to be on the Board of Paisabazaar as Non-Executive Director.

Policybazaar-parent PB Fintech’s net profit jumps 92% to Rs 72 crore in Q3, revenue up 48%

The parent company of Policybazaar announced its results for Q3 FY25 in an exchange filing on January 30.

Policybazaar to enter healthcare business in FY26, says CEO Sarbvir Singh

Policybazaar will also strengthen its foothold in the lending arena, with Paisabazaar pivoting from unsecured lending to an optimal mix from secured and unsecured loans, says Singh

GST authorities search PB Fintech’s Gurgaon office over evasion allegations

PB Fintech, owns and operates Policybazaar, which offers an array of insurance products and advisory services.

PB Fintech stock tanks 7% after Morgan Stanley downgrade to 'underweight' forecasting 25% downside

Looking ahead, Morgan Stanley expects PB Fintech's stock to de-rate as core new business performance moderates in FY26.

PB Fintech stock dips as UBS downgrades to Sell but raises target

PB Fintech's new initiatives will help it achieve EBITDA break-even by FY27, and a steady renewals pool should support long-term profitability, said UBS.

PB Fintech's Q2 revenue surges 44%, reports fourth straight quarter of profit

The company reported a 69 percent growth in the health and life insurance segment with a total insurance premium collection of Rs 5,450 crore during the quarter

PB Fintech stock gets thumbs up from Jefferies on $100 million healthcare investment

Jefferies issues a 'buy' call on PB Fintech with a target price of Rs 1,800, following a $100 million investment plan in a new healthcare venture, while maintaining an asset-light balance sheet.

PB Fintech healthcare foray via separate entity, company will act as minority investor: Group CEO Yashish Dahiya

Dahiya said the new entity plans to acquire 6-8 hospitals in the NCR region. While it’s still too early to discuss specifics, he sought to clarify to prevent any misinformation that could lead to financial losses for investors

PB Fintech stock jumps 3% after co clarifies healthcare plan, proposes one-time minority investment

PB Fintech shares jumped 3% to Rs 1,700 on September 30 after the company clarified plans for a one-time minority investment in a healthcare venture. Chairman Yashish Dahiya said the company intends to acquire a 20-30% stake for up to $100 million.